CompanyDrug

BeiGene’s Tislelizumab Receives CHMP Recommendation for Three NSCLC Indications in Europe

CompanyDeals

Shanghai Fosun Pharmaceutical Partners with Nanning City to Broaden Collaboration in Biopharma and Beyond

CompanyDrug

Everest Medicines Gets CDE Approval for Global Phase IIb Study of Zetomipzomib in Lupus Nephritis

CompanyDrug

Alvotech Scores FDA Nod for Interchangeable High-Concentration Biosimilar to Humira

Company

BeiGene Reports Record Revenues and Rapid Growth in Q4 and Full Year 2023 with Continued Expansion

CompanyDeals

Novo Nordisk Partners with Neomorph to Target Undruggable Diseases with Molecular Glue Degraders

Company

AstraZeneca Expands Global Footprint with Shanghai Strategic Center

CompanyDeals

Simcere Pharmaceutical’s Oncology Unit Raises RMB 970 Million to Advance Cancer Drug Development

CompanyDeals

Kelun-Biotech Launches Clinical Trials for SKB264, Triggering $75 Million Milestone Payment from MSD

CompanyDrug

AstraZeneca Launches Phase I Trial for siRNA Therapy in Collaboration with Silence Therapeutics

CompanyDeals

b-ONE Ortho Partners with THINK Surgical to Expand MOBIO Knee System in U.S. Market

CompanyDeals

CardioACC Initiates Regulatory Study for Groundbreaking 7.5F Intracardiac Ultrasound System